END STAGE RENAL DISEASE
Clinical trials for END STAGE RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Nurse-Led program reverse frailty in dialysis patients?
Disease control CompletedThis study tests whether a 3-month nurse-led program can reduce frailty and improve self-management in people undergoing peritoneal dialysis. The program includes personalized assessments, education, exercise training, and social support. Researchers compare this program to stand…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Henan University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New PTH test could Fine-Tune mineral balance in kidney dialysis
Disease control CompletedThis study looks at whether a new method of measuring parathyroid hormone (PTH) can help doctors better manage calcium and phosphate levels in people on hemodialysis. About 80 patients with end-stage kidney disease will be randomly assigned to have their PTH measured either with …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New dialyser aims to cut blood thinner risks for kidney patients
Disease control CompletedThis study compares two dialysis filters, SOLACEA-H and HYDROLINK-NVU, to see if SOLACEA-H can allow dialysis sessions with less or no blood thinner (heparin). The trial involves 20 adults who have been on dialysis for at least 3 months and are medically stable. Each participant …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney transplant drug showdown: which regimen saves more function?
Disease control CompletedThis study tested two different combinations of immunosuppressant drugs in 88 adults who received a new kidney. The goal was to see which plan better protects kidney function over the short term. All participants took lifelong anti-rejection medication, so this is about managing …
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Dialysis patients learn to lower potassium through diet
Disease control CompletedThis study tested whether face-to-face nutrition education about potassium could help people on maintenance hemodialysis control their potassium levels. Fifty adult patients with high potassium took part. The goal was to reduce complications and improve quality of life.
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Dialysis fluid shows promise in slowing artery hardening
Disease control CompletedThis study looked at whether adding citrate to the fluid used during dialysis can slow the buildup of calcium in blood vessels. 54 adults on hemodialysis who already had some vessel hardening took part. Each person used a standard fluid for 12 months and a citrate fluid for anoth…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Breakthrough drug may give hope to kidney patients rejected for transplant
Disease control CompletedThis study tested a drug called imlifidase in 113 highly sensitized kidney patients who had a positive crossmatch against a deceased donor. The drug was given before transplant to reduce the risk of rejection. The main goal was to see how many patients still had a working kidney …
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to improve kidney transplant success
Disease control CompletedThis phase 2 trial tested a new combination of drugs—siplizumab, belatacept, and mycophenolic acid—in 76 people who just received a kidney transplant. The goal was to see if this combo is safer and works better than the usual immunosuppression therapy. Researchers measured side e…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Breakthrough drug could open door to kidney transplants for 'Impossible' patients
Disease control CompletedThis phase 3 trial tested a drug called imlifidase in 64 highly sensitized kidney transplant patients who had almost no chance of finding a compatible donor. The drug breaks down harmful antibodies, allowing a transplant from a donor that would normally be rejected. The study mea…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Which IV fluid is best after a kidney transplant? new study has answers
Disease control CompletedThis study compared two types of IV fluids given to kidney transplant patients during their first week after surgery. The goal was to see which fluid better prevents electrolyte imbalances and helps the new kidney work well. About 159 adult patients who received a kidney from a l…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New tacrolimus tablet tested in kidney transplant patients
Disease control CompletedThis study looked at how a tacrolimus tablet (TacroBell) works in people who received a kidney transplant. The goal was to measure drug levels in the blood and see how well patients tolerated it. 128 adults who were getting a kidney from a deceased or living donor took part. The …
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Kidney transplant study: which drug better prevents rejection?
Disease control CompletedThis study tested two different drug combinations (Simulect or ATG, plus standard medications) in 60 kidney transplant patients at high risk of rejection. The goal was to see which approach better prevents treatment failure, including rejection, graft loss, or death, within 6 mon…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New dialysis filter shows promise in small kidney study
Disease control CompletedThis study tested a new dialysis filter (Clearum HS) in 20 adults with end-stage kidney disease who were already on dialysis. The goal was to see if the new filter safely removes waste products like urea as well as or better than standard filters. Participants used their usual fi…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Mozarc Medical US LLC • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Smart dosing of blood thinner could save kidneys in children
Disease control CompletedThis study tested a personalized way to dose the blood thinner enoxaparin in 50 children after kidney transplant. The goal was to prevent dangerous blood clots in the new kidney while avoiding excessive bleeding. Doctors used a computer model (Bayesian approach) to adjust doses b…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for dialysis patients with blocked chest veins
Disease control CompletedThis study looked at 45 adults on hemodialysis who had a blocked superior vena cava (SVC), a large vein in the chest. Doctors used surgery or a tube-like device to reopen the vein and relieve symptoms. The goal was to improve blood flow and quality of life for these patients.
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could hepatitis c kidneys solve the organ shortage?
Disease control CompletedThis study tested whether kidneys from deceased donors with hepatitis C can be safely transplanted into people without hepatitis C. All 201 participants received antiviral medication after transplant to clear any infection. The goal was to see if this approach could safely increa…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New dialyzer shows promise in small safety trial
Disease control CompletedThis study tested a new dialysis filter called ELISIO-HX in 22 adults with kidney failure. Participants used the new filter three times a week for 12 weeks. The goal was to see if it safely maintained albumin levels while improving removal of certain waste products. The trial is …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Nipro Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Stem cell trick may let kidney patients ditch daily pills
Disease control CompletedThis study tests whether giving donor stem cells and a drug called Campath-1H can help kidney transplant recipients stop taking anti-rejection medications permanently. Eighty-eight patients receiving a kidney from an identical sibling will get the stem cell infusions and temporar…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Kidney transplant breakthrough: could this be the end of lifelong pills?
Disease control CompletedThis early-stage study tested a new approach to help kidney transplant recipients stop taking anti-rejection drugs. Eight adults received donor stem cells along with a special mix of medications to see if their bodies would accept the new kidney without needing lifelong drugs. Th…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New shot may keep dialysis grafts open longer in kidney patients
Disease control CompletedThis study tested an experimental drug called MK-2060 in 506 adults with end-stage kidney disease who need regular dialysis through a special tube (graft) in their arm. The goal was to see if the drug could prevent dangerous blood clots from blocking the graft, which would requir…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Smart scale for dialysis: could it prevent heart attacks?
Disease control CompletedThis study tested whether using a special scale (bioimpedance) to measure body fluid levels each month could help doctors set the right dry weight for hemodialysis patients. The goal was to reduce serious complications like heart attacks, strokes, and low blood pressure during di…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Cishan Hospital, Ministry of Health and Welfare • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Monthly blood filter may extend life for dialysis patients
Disease control CompletedThis study examined whether adding a monthly blood-cleaning procedure (hemoperfusion) to regular dialysis can reduce the risk of death, especially from heart or brain problems. Researchers reviewed records of 879 adult dialysis patients over 10 years, comparing those who received…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Yunfeng Xia • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug shows promise in preventing kidney rejection
Disease control CompletedThis study tested a new drug called FR104 in 10 people who received a kidney transplant. The goal was to see if the drug is safe and helps prevent the body from rejecting the new kidney. Researchers monitored side effects and kidney function over time.
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New gadget boosts fluid removal for kidney patients on home dialysis
Disease control CompletedThis study tested a device called Carry Life UF in 28 adults with end-stage kidney disease who use continuous ambulatory peritoneal dialysis (CAPD) at home. The device adds glucose to the dialysis fluid already in the belly to help remove more fluid over a 5-hour session. Researc…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Triomed AB • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Vitamin c may cut anemia drug needs in kidney patients
Disease control CompletedThis study looked at whether taking vitamin C by mouth can safely lower the amount of erythropoietin (a drug for anemia) needed by people with end-stage kidney disease on regular dialysis. Sixty adults on stable dialysis with low iron levels and moderate anemia took part. Researc…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug could change how we prevent kidney rejection
Disease control CompletedThis study tested a new medicine called ASKP1240 in 149 people who received a new kidney. The goal was to see if it could prevent the body from rejecting the kidney as well as or better than current standard treatments. Participants received different combinations of drugs, and r…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Engineered blood vessel could simplify dialysis for kidney patients
Disease control CompletedThis phase 3 trial tested a lab-grown blood vessel (Human Acellular Vessel, or HAV) against the standard surgically created fistula in 242 people with end-stage kidney disease on hemodialysis. The goal was to see which option works better for providing reliable access to filter b…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New kidney drug shows promise in early safety trial
Disease control CompletedThis study tested a single dose of a new drug called ASKP1240 in 50 people who just received a kidney transplant. The goal was to see how the drug moves through the body, how safe it is, and how well it works. Participants were randomly assigned to get the drug or a placebo, and …
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New implant could keep dialysis lifelines open longer
Disease control CompletedThis study tested a special collagen implant coated with sirolimus (rapamycin) placed around a new dialysis fistula during surgery. The goal was to see if it helps the fistula become usable for dialysis sooner and stay working longer. About 269 people with advanced kidney disease…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New implant could speed up dialysis fistula maturation
Disease control CompletedThis phase 3 trial tests a sirolimus-releasing collagen implant placed around a new dialysis fistula during surgery. The goal is to help the fistula mature faster so it can be used for dialysis. The study involves 136 people aged 65+ with kidney failure who are new to hemodialysi…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gene test could Fine-Tune transplant drug dosing
Disease control CompletedThis study tested whether adjusting the first dose of the immunosuppressant drug tacrolimus based on a patient's CYP3A5 gene helps reach the right blood levels faster after kidney transplant. 280 kidney transplant recipients were randomly assigned to receive either a standard dos…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental kidney drug MK-2060 passes first safety check in small study
Disease control CompletedThis early study tested a single shot of an experimental drug called MK-2060 in 14 people with stage 4 chronic kidney disease. The main goal was to see if it was safe and how the body handles it. Only the first part of the study was completed; the later parts were not started for…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 26, 2026 15:37 UTC
-
Home dialysis device gets safety check in ongoing study
Disease control CompletedThis study allowed 25 people with end-stage kidney disease to keep using the HemoCare hemodialysis system at home while the device was being reviewed for market approval. The main goal was to track safety events like side effects or device problems. Participants needed a trained …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Deka Research and Development • Aim: Disease control
Last updated Jun 26, 2026 14:41 UTC
-
Can a thymus gland protein shield dialysis patients from COVID-19?
Prevention CompletedThis Phase 2 trial tested whether thymalfasin, a synthetic version of a natural immune-boosting protein, could prevent COVID-19 infection in 189 kidney dialysis patients. These patients are at high risk due to weakened immune systems and frequent clinic visits. The study measured…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: William B. Ershler, MD • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Music and acupressure may soothe dialysis needle pain
Symptom relief CompletedThis study tested whether listening to music and applying acupressure before needle insertion can reduce pain in dialysis patients. 72 participants were split into four groups: music plus acupressure, acupressure alone, music alone, or standard care. Pain was measured during thre…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Gülsüm Gülşen • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Dialysis itch relief: could a simple education program be the answer?
Symptom relief CompletedThis study tested whether a structured education program could help people on dialysis manage chronic itch and improve their quality of life. 104 adults with kidney failure and itch took part, receiving either two educational sessions or standard care. The program focused on unde…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Dialysis patients get a workout boost in new study
Symptom relief CompletedThis study tested whether a combined aerobic and resistance exercise program could improve physical function and muscle health in people receiving peritoneal dialysis. Thirty-six adults on dialysis for at least six months were split into an exercise group and a usual-care group. …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Dilek GİBYELİ GENEK • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New dialysis method aims to cut recovery time for kidney patients
Symptom relief CompletedThis pilot study tested an optimized dialysis technique using a special membrane and biofeedback software to see if it helps kidney failure patients recover faster after treatment. 18 patients on standard dialysis who took at least 4 hours to recover were observed. The study meas…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Ramsay Générale de Santé • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
VR goggles take the sting out of dialysis needles
Symptom relief CompletedThis study tested whether wearing virtual reality goggles during the needle stick for dialysis can lower pain and anxiety. Fifty adults on hemodialysis were randomly assigned to either watch VR content during the procedure or receive usual care. The results will show if a simple,…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Laughter may be the best medicine for dialysis patients
Symptom relief CompletedThis study looked at whether online laughter therapy could help people on hemodialysis feel less depressed, anxious, and stressed, and improve their quality of life. Sixty-nine adults who were on dialysis took part. They did laughter therapy sessions online. The results showed th…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Zonguldak Bulent Ecevit University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Simple massage and relaxation may soothe dialysis cramps
Symptom relief CompletedThis study tested whether massage and progressive muscle relaxation exercises can reduce the frequency and severity of muscle cramps in people undergoing hemodialysis. 79 patients participated, and the goal was to see if these non-drug approaches offer relief. The findings could …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Yalova • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Simple massage and stretching tested for dialysis cramps
Symptom relief CompletedThis study tested whether a 10-minute vibration massage or static stretching exercise could reduce the severity and duration of muscle cramps that often occur during hemodialysis. Thirty adults with chronic kidney disease on dialysis were randomly assigned to receive vibration ma…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Figen Akay • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Foot massage beats sleep training for dialysis patients' rest
Symptom relief CompletedThis study tested two non-drug methods—reflexology (foot massage) and sleep hygiene education—to improve sleep and comfort in 60 adults on hemodialysis. Both approaches helped, but reflexology was more effective. The results suggest a simple, drug-free option for better rest in d…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Ulfet Kral • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Cooling dialysis fluid may fight fatigue after treatment
Symptom relief CompletedThis study tested whether lowering the temperature of the dialysis fluid from 36.5°C to 36°C could reduce the tiredness patients often feel after dialysis. Fifty-seven adults on maintenance hemodialysis received three sessions of 'cold dialysis' over one week. Researchers measure…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Breathe away the pain: simple breathing tricks ease dialysis needle stress
Symptom relief CompletedThis study tested whether guided breathing exercises (4-7-8 breathing and diaphragmatic breathing) can help reduce pain, anxiety, and improve comfort during the needle insertion for dialysis. 90 adults on hemodialysis were split into three groups: two doing different breathing ex…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Emine Kaplan Serin • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Simple oral care reminder cards may boost health in dialysis patients
Symptom relief CompletedThis study tested whether giving oral care education and reminder cards to adults on hemodialysis could improve their oral health and help them adjust to their chronic disease. 82 patients received one-on-one training, a reminder card, and a checklist to track daily oral care. Re…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Çanakkale Onsekiz Mart University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Dialysis patients try exercise to ease symptoms
Symptom relief CompletedThis study looked at whether a 26-week exercise program, including home-based resistance training and cycling during dialysis, could reduce symptom burden and improve quality of life in 133 adults with end-stage kidney disease on chronic hemodialysis. Participants were assessed a…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Dialysis patients get a boost: nurse-led program targets sleep, mood, and mobility
Symptom relief CompletedThis study tested whether a 12-week nurse-led program could help people on hemodialysis feel better and function better. 220 patients were split into two groups: one got the extra program during dialysis sessions, and the other got standard care. The program included light exerci…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Norther Private Collage of Nursing • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
VR headsets could take the sting out of dialysis needles
Symptom relief CompletedThis study tested whether watching calming VR videos (nature, forest, seaside) during needle insertion could reduce pain, distress, and improve comfort in 52 hemodialysis patients. Patients used VR headsets starting three minutes before the procedure. The goal was to see if this …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Tarsus University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Art during dialysis: a creative way to ease symptoms?
Symptom relief CompletedThis study tested whether doing art therapy during hemodialysis sessions can reduce common symptoms like fatigue and discomfort, and improve patients' sense of spiritual well-being. Sixty adults on dialysis took part; half received at least 30 minutes of art therapy per session w…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Uludag University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New nerve block may ease pain after kidney transplant
Symptom relief CompletedThis study tested whether a nerve block called an erector spinae plane (ESP) block can reduce pain and the need for strong painkillers after a kidney transplant. Forty adults having a kidney transplant were randomly assigned to receive either the ESP block or no block. All patien…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Virtual reality museum tours could ease dialysis symptoms
Symptom relief CompletedThis study tested whether virtual museum visits using VR glasses during hemodialysis can reduce symptoms and anxiety. Sixty patients were randomly assigned to either a virtual museum tour or standard care. The goal was to see if this simple, non-drug approach improves well-being …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Cumhuriyet University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Which nerve block eases kidney transplant pain better?
Symptom relief CompletedThis study compared two types of nerve blocks — erector spinae plane block and transmuscular quadratus lumborum block — for pain after kidney transplant. Forty adults received one of the two blocks with bupivacaine. Researchers measured pain scores and painkiller use over 24 hour…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Kocaeli Derince Education and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Lavender inhalation eases dialysis headaches and anxiety, study finds
Symptom relief CompletedThis study tested whether inhaling lavender oil can reduce headache severity and anxiety in people undergoing hemodialysis. 62 patients were split into two groups: one inhaled lavender oil during dialysis sessions for 4 weeks, while the other received standard care. Researchers m…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Goknur Demir Hacimusalar • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Simple home workouts may ease mental distress for kidney dialysis patients
Symptom relief CompletedThis study looked at whether a simple home-based exercise program could help reduce anxiety and depression in people receiving hemodialysis. 54 adults on dialysis were split into two groups: one did home exercises for 6 months, the other did not. Researchers measured changes in d…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Oman Ministry of Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Dialysis patients get better sleep with simple education and coaching
Symptom relief CompletedThis study tested whether sleep hygiene education plus motivational interviewing can improve sleep and quality of life in people on hemodialysis. Forty patients were split into two groups: one received face-to-face sleep training plus four online motivational sessions over six we…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Akdeniz University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Simple hand exercise may boost dialysis success
Symptom relief CompletedThis study tested if doing hand grip exercises for six weeks helps the arm blood vessel connection (fistula) used for dialysis grow stronger and work better. 34 adults with kidney failure on dialysis were randomly assigned to either do the exercises or receive standard care. The …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Talking it out: psychotherapy may ease depression in dialysis patients
Symptom relief CompletedThis study tested whether interpersonal psychotherapy-based counseling could help people on hemodialysis adjust to their illness and reduce depression. 48 adults who had been on dialysis for at least 6 months were split into two groups: one received the counseling for 8 weeks, th…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Jun 26, 2026 18:36 UTC
-
Dialysis patients share what they really think about treatment
Knowledge-focused CompletedThis study looked at how dialysis patients personally feel about their treatment. Researchers asked 26 adults with kidney failure to rank 24 statements about their experience. The goal was to better understand their perspectives, not to test a new drug or device.
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Yuzuncu Yil University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Ultrasound could help dialysis patients hit the right fluid balance
Knowledge-focused CompletedThis study looked at whether a special ultrasound check (called VExUS) can help doctors set the ideal dry weight for people on hemodialysis. The idea is that by spotting hidden fluid buildup, doctors can safely remove more fluid during dialysis to better control blood pressure. T…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Fundación Senefro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New study aims to predict early death risk in elderly kidney patients
Knowledge-focused CompletedThis study follows people over 75 with advanced chronic kidney disease to better understand their health and treatment paths. Researchers want to create a tool that predicts which patients are at high risk of dying soon after starting dialysis. The goal is to help patients, famil…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New equation could simplify salt monitoring for kidney dialysis patients
Knowledge-focused CompletedThis study aims to create and test a new mathematical formula that estimates how much sodium (salt) people on peritoneal dialysis consume. The researchers will enroll 30 adults who have been on peritoneal dialysis for at least three months and have no remaining kidney function. I…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Kidney transplant study compares immune effects of two common drugs
Knowledge-focused CompletedThis study looked at 49 kidney transplant patients to see how two different induction therapies—thymoglobulin and basiliximab—affect B cells, a type of immune cell. Researchers compared the B cell profiles between the two groups and with data from patients who had chronic antibod…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Kidney health may change how this drug works
Knowledge-focused CompletedThis study looked at how the drug LY3502970 behaves in people with healthy kidneys compared to those with kidney problems. Researchers measured how much drug gets into the blood and how fast the body clears it. The goal is to understand if kidney impairment changes drug levels, w…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Study aims to find best dialysis access for seniors
Knowledge-focused CompletedThis study looked at 166 older adults (65+) on hemodialysis to compare three types of vascular access: fistulas, grafts, and catheters. The goal was to see which option leads to fewer complications and better quality of life. Researchers tracked how many procedures were needed to…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New approach to CPR talks may help patients and families feel heard
Knowledge-focused CompletedThis study tested a new way for doctors to discuss CPR with older, seriously ill patients and their families. Instead of the usual conversation, doctors followed a step-by-step guide that focused on the patient's values and explained why CPR might not help. The goal was to see if…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2, PHASE3 • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can mailed videos help more patients get kidney transplants?
Knowledge-focused CompletedThis study tested a home education program called Explore Transplant@Home for nearly 1,000 patients with chronic kidney disease. The program mailed videos, postcards, and texts to teach about kidney transplant options, especially from living donors. The goal was to see if this ap…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New implant aims to simplify dialysis fistula monitoring
Knowledge-focused CompletedThis study tested a new device called EchoMark LP, which is implanted near a surgically created blood vessel connection (fistula) used for dialysis. The device works with a special ultrasound system (EchoSure) to measure blood flow, depth, and diameter of the fistula. The trial i…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Sonavex, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Dialysis patients wear heart monitors for a week to uncover hidden risks
Knowledge-focused CompletedThis study followed 268 adults with end-stage kidney disease on dialysis. Each participant wore a Holter heart monitor for 7 days to track irregular heartbeats. Researchers then looked for links between those heart patterns and serious outcomes like sudden cardiac death, heart at…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Islet transplants after kidney: a game changer for type 1 diabetes?
Knowledge-focused CompletedThis study looked at whether getting an islet transplant after a kidney transplant helps people with type 1 diabetes avoid kidney failure or death. Researchers reviewed data from 327 people in France who had a kidney transplant between 2000 and 2017. They compared those who also …
Matched conditions: END STAGE RENAL DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Video lessons boost kidney transplant knowledge
Knowledge-focused CompletedThis study tested whether a program of videos and text messages (called KidneyTIME) helps people with kidney failure learn more about getting a kidney from a living donor. 422 adults who were already being evaluated for a kidney transplant took part. The study compared those who …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New program helps dialysis patients and families make tough end-of-life decisions together
Knowledge-focused CompletedThis study tested a program called SPIRIT that helps kidney dialysis patients and their families plan for end-of-life care. The program involved two face-to-face sessions to improve communication and decision-making. Researchers enrolled 852 patients and their surrogates from dia…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New formula may help dialysis timing save lives
Knowledge-focused CompletedThis study looked at whether starting dialysis at a specific time, based on a new mathematical formula, could help people with end-stage kidney disease live longer. 388 patients were randomly assigned to start dialysis either at an 'optimal' or 'late' time. Researchers tracked de…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: The First Affiliated Hospital of Dalian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Emergency dialysis disconnect: do patients know how?
Knowledge-focused CompletedThis study looked at whether people on hemodialysis know how to safely disconnect themselves from the dialysis machine during an emergency, like a fire or power outage. Researchers tested 620 patients from multiple countries using a checklist. The goal was to see if patients coul…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New conversation tool aims to improve End-of-Life care for kidney patients
Knowledge-focused CompletedThis study tested a communication tool called 'Best Case/Worst Case' for older adults with advanced kidney disease. Doctors were trained to discuss best, worst, and most likely outcomes for treatment options. The goal was to see if this approach helps patients receive more pallia…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Transplant lifesaver linked to cancer risk: study investigates
Knowledge-focused CompletedThis study looked at 2,500 kidney transplant patients to find out why some develop cancer. The main focus was on the immunosuppressive drugs that prevent organ rejection, which can also raise cancer risk. Researchers tracked patients from four regions in France over 10 years to i…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New tool helps kidney patients decide on organ offers
Knowledge-focused CompletedThis pilot study tested a shared decision-making tool called the Donor Offer Plan (DOP) for people on the kidney transplant waiting list. 100 participants reviewed an online education module and discussed their donor preferences with a transplant nurse. The goal was to see if thi…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Hennepin Healthcare Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Kidney transplant drug dosing gets a closer look
Knowledge-focused CompletedThis completed study looked at how the drug Advagraf (a form of tacrolimus) works in 45 adults who received a kidney transplant. The goal was to find better ways to dose the drug by measuring its levels in the blood right after transplant and three months later. Researchers compa…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Kidney dialysis patients: new study tests blood thinner safety
Knowledge-focused CompletedThis study looks at how a single 5 mg dose of the blood thinner apixaban is processed in people with end-stage kidney disease who are on peritoneal dialysis, compared to people with normal kidney function. Researchers measured drug levels in the blood over time. The goal is to un…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New coaching program helps seniors decide on dialysis with confidence
Knowledge-focused CompletedThis study tested a program called DIAL-SDM that trains kidney doctors and coaches older patients (65+) with advanced kidney disease to have better conversations about dialysis. The goal was to see if the program was practical and acceptable. 102 patients, their caregivers, and 2…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Emergency dialysis: a closer look at who starts treatment in crisis
Knowledge-focused CompletedThis study aimed to find out how often people in Reunion Island start dialysis as an emergency and what social or medical factors lead to that. Researchers followed 233 adult patients beginning dialysis at local centers. The goal was to gather information to improve care and redu…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Dialysis danger: study seeks safer fluid removal to prevent blood pressure crashes
Knowledge-focused CompletedThis study looked at 50 adults on maintenance hemodialysis to find the link between how fast fluid is removed (ultrafiltration rate) and sudden drops in blood pressure during treatment. The goal was to identify a safer threshold to prevent intradialytic hypotension. Researchers a…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Dialysis patients get a pecha kucha boost for diet and fluid rules
Knowledge-focused CompletedThis study tested whether a fast, concise presentation style called Pecha Kucha (20 slides, 20 seconds each) can improve how well hemodialysis patients follow their diet and fluid restrictions. Sixty patients took part, and researchers measured their attitudes toward diet therapy…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Dialysis study questions need for routine access checks
Knowledge-focused CompletedThis study looked at whether it is safe to stop regularly checking blood flow in the arm veins used for dialysis. Instead, doctors would only treat problems when they cause symptoms during dialysis. The goal was to see if this approach reduces the number of procedures and medical…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Doctors' beliefs may shape dialysis choices: new study investigates
Knowledge-focused CompletedThis study looked at how kidney doctors (nephrologists) think about choosing the right dialysis treatment for patients with kidney failure. Researchers interviewed 25 doctors across Belgium to understand their beliefs and attitudes. The goal is to find out if doctors' own views a…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Erasme University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New study aims to prevent dangerous blood pressure drops during dialysis
Knowledge-focused CompletedThis study tested whether teaching dialysis staff and providing support to patients could reduce episodes of dangerously low blood pressure during treatment. Over 1,400 patients across multiple clinics took part. The goal was to make dialysis sessions safer and more stable.
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Hidden prediabetes common in dialysis patients, study finds
Knowledge-focused CompletedThis study looked at how common prediabetes is in people with end-stage kidney disease who are on dialysis. Researchers screened 262 adult dialysis patients who had never been diagnosed with diabetes or prediabetes. The goal was to find out how many had prediabetes, which can inc…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New kidney drug passes early safety check in small study
Knowledge-focused CompletedThis early-stage study tested a single dose of the experimental drug KBP-5074 in 11 people with severe chronic kidney disease, including some on dialysis. The main goal was to check safety and how the drug moves through the body. No treatment benefits were measured; the study onl…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: KBP Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can a friend be your kidney donor champion? new program tested
Knowledge-focused CompletedThis study tested a program called the Live Donor Champion Program, which trains a friend or family member to help a kidney patient find a live donor. The program was offered to 111 patients on the kidney transplant waitlist. Researchers wanted to see if the program could be succ…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Kidney perfusion fluid may hold clues to transplant quality
Knowledge-focused CompletedThis study looked at whether analyzing the fluid used to preserve kidneys on a LifePort® machine could help predict how well the kidney will work after transplant. Researchers measured chemicals in the fluid and compared them to early kidney function in 40 recipients. The goal is…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Planning ahead: study tests if care wishes are honored
Knowledge-focused CompletedThis study looked at whether a special planning tool, called a POST form, helps older adults (65+) get the medical care they prefer at the end of life. Researchers worked with 389 people, including those with dementia, to see if their treatment matched their wishes. The goal was …
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Biopsy clues: will the new kidney work?
Knowledge-focused CompletedThis study looked at small pieces of donor kidney tissue to see if certain substances could predict how well the organ would work after transplant. Researchers tested blood, urine, and biopsy samples from 24 kidney transplant recipients. The goal was to find early signs of organ …
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Kidney patients needed for drug dosing study
Knowledge-focused CompletedThis completed Phase 1 study looked at how different levels of kidney function affect the way the body processes a single dose of the drug AZD6234. Researchers compared 24 adults with various degrees of kidney impairment to healthy volunteers. The goal was to understand how the d…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Kidney patients needed to test drug safety
Knowledge-focused CompletedThis study looked at how the drug BMS-986278 behaves in people with normal kidneys, severe kidney disease, or kidney failure on dialysis. 27 adults took a single dose to measure drug levels and check for side effects. The goal was to gather safety information, not to treat the di…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Vitamin d levels checked for clues to heart risk in kidney patients
Knowledge-focused CompletedThis study looked at whether vitamin D levels in the blood are related to early signs of artery hardening (atherosclerosis) in people on dialysis. Researchers measured vitamin D and used ultrasound to check artery thickness in 90 adults with kidney failure. The goal was to see if…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Dialysis sparks new insights: tiny electrical changes measured
Knowledge-focused CompletedThis pilot study looked at how hemodialysis changes the electrical properties of skin and muscle in 18 adults on chronic dialysis. Researchers measured these changes to better understand fluid shifts during treatment. The goal was to gather knowledge, not to test a new treatment.
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Navigators may bridge kidney transplant gap for minorities and women
Knowledge-focused CompletedThis study tested whether trained transplant navigators could help kidney failure patients complete the steps needed to get a kidney transplant. About 167 adults on dialysis were assigned to either a navigator or usual care. The navigator provided tailored help and information to…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Case Western Reserve University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC